Tespral enhances the movement of food from stomach to intestine. It is indicated for the treatment of functional or non-ulcer dyspepsia and gastroparesis.
This medicine is indicated as a short-term therapy for gastroesophageal refluz disease (GERD). It also treats erosive esophagitis, Zollinger-Ellison Syndrome and other disorders associated with excessive gastric acid secretion